MemorEM for Neurological Diseases

This trial tests a device called MemorEM to evaluate its potential benefits for people with neurological diseases. The main goal is to gather feedback from patients and their caregivers about their experiences using the device. Researchers aim to determine if it could assist with diseases beyond Alzheimer's, such as Parkinson's or Frontotemporal dementia. Individuals diagnosed with a neurological disease characterized by protein buildup, like Alzheimer's or Parkinson's, and who have a caregiver, might be suitable for this trial. Participants will use the device and provide feedback but will not undergo any other treatments. As an unphased trial, this study offers patients a unique opportunity to contribute to innovative research and potentially benefit from new therapeutic approaches.

The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with your doctor to ensure it is safe to continue your current treatment while participating in the trial.

Research has shown that the Western Institutional Review Board rated the MemorEM device as a "Non-Significant Risk." This rating is based on a previous trial and two follow-up studies, which found no safety issues over two and a half years of use.

Another study examining safety and early effectiveness found that the MemorEM device did not cause any major side effects in patients with mild to moderate neurological conditions. This indicates that the device is generally safe when used as directed.

MemorEM is unique because it uses electromagnetic fields to target neurological diseases, offering a non-invasive alternative to traditional drug-based therapies. Unlike standard treatments that often involve medications with potential side effects, MemorEM provides a novel approach by directly influencing brain activity through electromagnetic stimulation. Researchers are excited about this treatment because it has the potential to improve symptoms with fewer side effects and greater precision in targeting affected brain areas.

Research suggests that the MemorEM device, used by participants in this trial, might improve memory in people with Alzheimer's. One study showed that daily use of the device for two months seemed to reverse memory decline in most patients. Another study found that this treatment could help balance certain chemicals in the blood and brain linked to Alzheimer's. Although these results are encouraging, they come from small studies. Larger studies are needed to confirm the device's effectiveness for different brain diseases.¹²⁶⁷⁸